Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

about

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

Item

http://www.wikidata.org/entity/Q58764411

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@en

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@nl

type

Item

label

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@en

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@nl

prefLabel

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@en

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@nl

P1476

Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma

@en

P2093

Hunter John Piegols

http://www.w3.org/2001/XMLSchema#string

Maciej Parys

http://www.w3.org/2001/XMLSchema#string

Marilia Takada

http://www.w3.org/2001/XMLSchema#string

Thomas Dexheimer

http://www.w3.org/2001/XMLSchema#string

Vilma Yuzbasiyan-Gurkan

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains

Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis

New small molecules targeting apoptosis and cell viability in osteosarcoma

Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.

High-dose leucovorin as sole therapy for methotrexate toxicity.

Subset of patients with verrucous carcinoma of the oral cavity who benefit from treatment with methotrexate.

Principles of early drug discovery.

Mechanisms of action of flavopiridol.

Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma

MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosis.

P304

33098-33109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.26006

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30237854

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6145701

http://www.w3.org/2001/XMLSchema#string